AXA stock trades steadily as capital strength and dividend support valuation

AXA stock is underpinned by higher recent earnings and a rising dividend, with the French insurance group AXA S.A. (ISIN FR0000120620) highlighting stronger capital generation and cash flows in its latest annual report for fiscal 2024. According to AXA's investor materials dated 21 February 2025, the company reported higher underlying earnings and proposed a larger shareholder payout, providing a key reference point for the current valuation.

Underlying earnings rise in 2024

According to AXA's 2024 annual financial report released on 21 February 2025, AXA generated underlying earnings of around EUR 8.0 billion in fiscal 2024, compared with approximately EUR 7.2 billion in fiscal 2023, marking an increase of about EUR 0.8 billion year over year. The company attributed this growth to stronger profitability in property and casualty insurance, health insurance, and life and savings segments, supported by pricing discipline and portfolio management.

AXA's 2024 revenues, reported in the same annual document, were approximately EUR 101 billion, up from roughly EUR 97 billion in 2023, representing growth of about 4% over the prior year period. The increase was driven by higher premiums in commercial lines and continued expansion in health insurance, particularly in European markets and selected international operations. For investors, the combination of rising earnings and revenue growth provides a clearer basis to assess AXA stock relative to other large European insurers.

Solvency ratio and dividend support valuation

Capital strength remains a central metric for AXA. In its 2024 disclosure, AXA reported a Solvency II ratio of roughly 210% as of 31 December 2024, compared with about 208% at the end of 2023, indicating that the insurer's regulatory capital comfortably exceeded required levels and improved modestly year on year. This solvency ratio reaffirms the group's ability to absorb shocks and maintain policyholder protection while continuing capital returns to shareholders.

On the capital return side, AXA's board proposed a dividend of EUR 1.98 per share for fiscal 2024, up from EUR 1.79 per share for fiscal 2023, an increase of approximately 10.6%. The higher dividend reflects management's confidence in recurring earnings and cash generation. For long-term holders of AXA stock, the rising dividend and robust solvency ratio help frame expectations for income and capital resilience even as insurance cycles and interest rate trends shift over time.

Health insurance growth as a medium-term driver

Beyond headline earnings and capital metrics, AXA's health insurance activities have become a more important growth pillar. According to AXA's segment disclosures for 2024, health insurance revenues reached around EUR 17 billion, compared with approximately EUR 15.5 billion in 2023, representing growth of about 9.7% year on year. This expansion was supported by increased penetration of employer-sponsored health plans and individual policies, as well as digital tools that make claims and policy management more efficient for both customers and the insurer.

Health insurance margins also benefited from improved underwriting and claims management, with AXA signaling that health contributed meaningfully to overall underlying earnings growth in 2024. From an investor perspective, the rising revenue base in health, together with the group's scale in property and casualty insurance, suggests that AXA stock offers exposure to both traditional insurance cycles and structurally growing health-care related demand across Europe and selected emerging markets.

Property and casualty portfolio remains central

AXA's property and casualty (P&C) segment continues to represent a core part of the business. In its 2024 reporting, AXA indicated that P&C revenues were roughly EUR 39 billion, compared with about EUR 38 billion in 2023, a more moderate increase of around 2.6% year over year. The segment mixes retail motor and household policies with commercial lines such as liability and specialty risks, where rating adjustments and risk selection have been key priorities.

Underwriting performance in P&C is often gauged through the combined ratio, which compares claims and expenses with earned premiums. For 2024, AXA reported a P&C combined ratio of approximately 93%, down from about 94% in 2023, showing a one percentage point improvement in profitability. This improvement indicates that the insurer collected enough premiums to cover claims and operating expenses while leaving a margin, reinforcing the case that AXA's P&C operations are contributing positively to group earnings and supporting the valuation of AXA stock.

Life and savings segments adapt to market conditions

AXA's life and savings businesses have been adjusting to a changing interest rate and savings environment. According to the company's 2024 disclosures, life and savings revenues were around EUR 45 billion, slightly higher than approximately EUR 44 billion the year before, indicating modest growth of about 2.3%. The segment includes protection products, unit-linked savings contracts, and traditional savings offerings, which respond differently to interest rate changes and equity market dynamics.

AXA has continued to emphasize protection and unit-linked products, which carry lower capital intensity and potentially more stable margins than some traditional savings guarantees. This strategic positioning, described in AXA's investor materials, aims to maintain profitability while managing capital consumption under Solvency II. For investors evaluating AXA stock, the tilt toward less capital-intensive products may be seen as a way to support both earnings quality and regulatory capital ratios over time.

Revenue up 4 percent in 2024

The overall revenue growth of around 4% in 2024 sets a numerical anchor for AXA's recent expansion. With group revenues rising from approximately EUR 97 billion in 2023 to about EUR 101 billion in 2024, AXA demonstrated that it could grow its business even in a competitive European insurance landscape. This uptick in top-line figures was not driven by one single segment but emerged from health, P&C, and life and savings, highlighting a balanced portfolio.

The revenue trajectory also interacts with cost discipline and underwriting outcomes. AXA's reported improvement in the P&C combined ratio to approximately 93% in 2024 suggests that management is consciously aligning pricing, risk appetite, and cost control to maintain or enhance margins while growing the business. In this context, AXA stock represents a claim on both recurring revenue and the company's effectiveness in turning that revenue into profit under evolving regulatory and market conditions.

Capital management and shareholder returns

Capital management decisions are particularly important for insurance groups, and AXA is no exception. As noted earlier, the group's Solvency II ratio was around 210% as of the end of 2024, modestly higher than approximately 208% at the end of 2023. This incremental improvement, even while the company raises its dividend, illustrates that AXA is generating capital through operations and managing its risk profile carefully.

In addition to dividends, AXA has historically considered other capital return mechanisms, such as share buybacks, when capital levels exceed internal targets and strategic needs. While specific buyback figures are subject to board decisions and regulatory considerations, the company's 2024 commentary indicated openness to balancing reinvestment in growth areas with returning excess capital to shareholders. For holders and potential buyers of AXA stock, the capital management framework can be a key element of the investment case, influencing both total return and risk perceptions.

Focus on climate and risk management

AXA has also integrated climate considerations into its risk management and underwriting processes. The insurer has signaled that it is reducing exposure to certain high-carbon sectors while supporting clients in the transition to lower-carbon activities. While such policies are not easily summarized in a single figure, they intersect with the financial metrics by influencing long-term risk profiles, potential claims variability, and allocation of capital.

Risk management beyond climate remains central. AXA's 2024 materials describe efforts to refine catastrophe risk models, cyber risk assessments, and health trend analyses. These tools underpin underwriting decisions and pricing across segments. The aim is to ensure that premiums adequately reflect risk, which in turn supports the combined ratio and underlying earnings figures that investors reference when analyzing AXA stock relative to peers.

Digitalization to improve efficiency

Digitalization has become a recurring theme for AXA. The group has been investing in digital tools for distribution, claims handling, and customer interaction, which can reduce administrative costs and improve customer satisfaction. Over time, efficiency gains may show up in operating expense ratios or improved retention, though these effects are often gradual and spread across multiple metrics rather than concentrated in a single headline number.

From a financial perspective, digitalization supports the company's ability to scale health and P&C offerings without proportionate increases in cost. If successful, this could reinforce the trend of rising underlying earnings seen between 2023 and 2024, where the increase from approximately EUR 7.2 billion to around EUR 8.0 billion reflects both revenue growth and margin improvement. For investors, digitalization is less a standalone story and more a lever behind the financial metrics underpinning AXA stock.

Product spotlight on health insurance offerings

AXA's health insurance products form a concrete example of how the group translates its strategy into services for end customers. The company offers a range of health plans, including employer-sponsored coverage, individual comprehensive health insurance, and supplementary products such as dental and optical cover, tailored to different markets and regulatory environments. These offerings often include access to digital health platforms, telemedicine services, and preventive care initiatives aimed at improving health outcomes and managing claims costs.

In 2024, the rise in health insurance revenues to around EUR 17 billion, up roughly 9.7% from approximately EUR 15.5 billion in 2023, shows that demand for AXA's health solutions is growing. The integration of digital services and broader coverage options helps AXA respond to demographic trends, such as aging populations and increased health awareness, while potentially differentiating its products from those of competitors. This makes the health segment an important reference point for investors when considering the long-term growth profile embedded in AXA stock.

AXA stock closing perspective

While the most recent intraday or closing price for AXA shares can vary by trading venue and time, the company remains one of the larger listed European insurers, with market capitalization typically measured in tens of billions of euros as of recent reporting dates. The combination of rising underlying earnings from approximately EUR 7.2 billion in 2023 to around EUR 8.0 billion in 2024, revenue growth from roughly EUR 97 billion to about EUR 101 billion over the same period, and a Solvency II ratio near 210% provides a quantitative framework for evaluating AXA stock in relation to both its own history and sector peers.

For investors, the key numbers now include the 4% revenue growth in 2024, the approximately one percentage point improvement in the P&C combined ratio to around 93%, and the proposed dividend increase from EUR 1.79 to EUR 1.98 per share. Together, these metrics suggest that AXA is generating more earnings, maintaining strong capital, and returning a growing share of profits to shareholders, all of which contribute to the ongoing assessment of AXA stock in diversified portfolios.